Atlas Venture Fund VII L P 13D/13G Filings for F-star Therapeutics, Inc. (FSTX)

Atlas Venture Fund VII L P 13D and 13G filings for F-star Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-02-03
5:20 pm
Purchase
2020-11-2013GF-star Therapeutics, Inc.
FSTX
Atlas Venture Fund VII L P574,996
6.300%
574,996increase
(New Position)
Filing